COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02098278
Recruitment Status : Completed
First Posted : March 28, 2014
Last Update Posted : July 21, 2016
Information provided by (Responsible Party):
Catabasis Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015
Certification/Extension First Submitted : July 19, 2016